Ingevity (NGVT) Research & Development (2016 - 2026)

Ingevity (NGVT) has 11 years of Research & Development data on file, last reported at $6.7 million in Q1 2026.

• On a quarterly basis, Research & Development fell 4.29% year-over-year to $6.7 million in Q1 2026; TTM through Mar 2026 was $28.9 million, a 7.04% increase from a year earlier, with the FY2025 full-year figure at $28.4 million, up 15.92% from the prior year.
• Research & Development for Q1 2026 stood at $6.7 million, down from $7.4 million in the prior quarter.
• Over the last five years, Research & Development for NGVT reached as high as $8.8 million in Q1 2023 and fell as low as $800000.0 in Q4 2023.
• Historically, Research & Development has averaged $7.0 million across 5 years, with a median of $7.3 million in 2022.
• Across the five-year window, Research & Development plunged 88.89% in 2023 and jumped 712.5% in 2024, its largest moves.
• Year by year, Research & Development stood at $7.2 million in 2022, then plunged by 88.89% to $800000.0 in 2023, then soared by 712.5% to $6.5 million in 2024, then rose by 13.85% to $7.4 million in 2025, then dropped by 9.46% to $6.7 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $6.7 million in Q1 2026, $7.4 million in Q4 2025, and $7.0 million in Q3 2025.